9999999997-13-003267.txt : 20130312
9999999997-13-003267.hdr.sgml : 20130312
20130312104618
ACCESSION NUMBER: 9999999997-13-003267
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20130312
DATE AS OF CHANGE: 20130312
20130312
20130312
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELITE PHARMACEUTICALS INC /NV/
CENTRAL INDEX KEY: 0001053369
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223542636
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15697
FILM NUMBER: 13682900
BUSINESS ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
BUSINESS PHONE: 2017502646
MAIL ADDRESS:
STREET 1: 165 LUDLOW AVENUE
CITY: NORTHVALE
STATE: NJ
ZIP: 07647
FORMER COMPANY:
FORMER CONFORMED NAME: ELITE PHARMACEUTICALS INC /DE/
DATE OF NAME CHANGE: 19980121
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(#`@;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@("`@#0HR
M,B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22`X-"],(#8X+TQE;F=T
M:"`V,"]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G``(.1@94`.*S,'`T((LQ
M0S$#0R,#-P/[*R>82I%NJ(XVL"X&%68(GY$;(,``BQ$#SPT*96YD%LP(#`@-C$R(#NP$"@P`2(&%@'S
MC(O!$QPX!1$9QX!1&L/5%;D]ZKM42ZW,^2YEF$7A?CHE25-K$\LRCLDF9HX^
M9CIXU39YJO2:K&X2DJFCWDRGAOYM!;]DV2ES6``CZ:S_3!=`/U%.LJ>#.M'->3((A@
MXE%AYJ-F<,K#C443617ETX>LJ%0'2_4;[IM*UA\MMI25(A8Q@(VOTLF\*;>+
MS.*I;I7.]V39M)4L;>C!M21,1U^T+(M\5N]*!92D6E7?S7\.W7S(Q9;;XJ";
MEOP8C6('G>E\K=UWFR+>D<>BGI6=\7I.RG:3E_O90L>OZB"#XV/]%7V
M#,8$21]_:FPH:Q^5[>S4GKEZJ_?=F@<4T`+J_-@0\SP/'`<9_[.>F^"\WW&%
MH8"0,1`BLLN+8LO">.S[CF?BR'%901!:U-U#3WXP5]'MOKEAV*G-Y")RDQ@?
MF4DP-O2(/*SON?CFO1(,GTN0BK=)\)_J\U]07\3?)[ZWZH[3"]UQ]@K=G0W?
M`=?KE$=/[WNI.JNU7CFH)WQ[A]A*O?(&12$Z9)V9]*^&RL':8V]5U/``0!A#EGG@0K8=N1XX^(NOU('826@2
M0+8?.?",?UDA'B\C`E;VS\A-P':I&T(VTRO9[WI@^S1-WW9MZCAN*J[KP+^]7RGQ,@^#$NK#I
M">.V'F'0=WE;[)"9,7B.ZZLXW8!&)S1<4A32-+J`;&AP-`WW#[/Y`]Q8=H*A
M/TQ6V7)U@^A6"PG+]1`7YL/<]O3MT%.WE[,YWIA\@>QA/LGN<*+9PHM1>!V0
M(EYXS&[G8.A"HN::'IA,,[A?@)OZ@GV/!-H@9N*4H"LQ>-2[P9?=WF[SPLV]+S(J\Y"!LD8EG5!E2=T]`L_F-@P.-'=@E<,5@T%%);MAE$:
M@PW3Q6]>ZB2Q0D:]$RF2O]_[D0>Q"`)5!((]#2)X4[=S'IY_#,]7X8%E>W'H
MO!^FCK`;-GM+9)KW/2LAKR$_'"H\T?.FAJ$N60L/5DQ],ECXP-B\8&-[T++O
M`^MZ7C\KDK#21"D=,7@:0]'46V34)[QD=<]S*T1?%?0M4\-^;Z7XPCU0YQI1
M#S%I@==FP<5GJ\XI6+P']K-0IBP;*W,HF5)G2GT4F6,HB0T<5\,I8=LV(N"0
M0+]C,/^YXQO>=]`WD,.B:?6>Z]A_P!9361KY*LOGI6/$;X2,T%;-#Z:*?8^L
M162C1(LLNH&L4X\>";N4DN+PO_/X*>\0#SIIV:%E'7(FZ4`>?-+!YA5.$BUS
M>I7M?I?W^."=8+@H/&D-NLCJO)8'I4=!342$7X^<2DSD8M$R5C9J#YJM(5Z9/1*/+>82
M^J3HQQ#"(UW3*84P])[(YLEZ(L&3-9:69_P'5_I(1%-PSNOX&^F$%?0X;=I#
MTRJC"RZ`,]AA["7K62ORF1!>OTDB.>LP4F:2M[KIA9X.PP8+J7J%DG=%U70,
M=4M!M0"')M&;3-UCQET%:%(435MB<56O8R'U"@5>FIS%*/C<-./0/9%[NCY8S-RW$@Y55TTD$'++OL&`."]
M/GN5+5.?"QWQ%*M#9HEW0EEC49I&AEIJ1HVI^Y:]\-BL8N7^'3F.D=VV&_):
M*DQ]\:657R$D)6;J.9?]?>AW3T'9/!O]*\``R;.O
M&0T*96YDG)E4WI.5&-Z:V,Y9"(_/@H\>#IX
M;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B
M92!835`@0V]R92`U+C(M8S`P,2`V,RXQ,SDT,SDL(#(P,3`O,#DO,C&UL.FQA;F<](G@M9&5F875L="(^36EC#PO&%P+S$N,"\B/@H@("`@("`@("`\>&UP.D-R96%T941A=&4^
M,C`Q,RTP,RTQ,E0Q,#HT,#HR,BTP-#HP,#PO>&UP.D-R96%T941A=&4^"B`@
M("`@("`@(#QX;7`Z0W)E871O&UL;G,Z<&1F/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI0&UP34TZ26YS=&%N8V5)1#YU=6ED.C`W-C@P.3EB+6,S93@M-&4U,"UA
M8S4S+6,S9F(P96-F9F4P8SPO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R
M9&8Z1&5S8W)I<'1I;VX^"B`@(#POJ'5!:DZ@?(PQ"@(Q$`"_LIU)86X3O4(10;Q6$!1M;&*R8B"ZQ]Z*/M\KK&V'
MF5D`PFK5;%YZ9S&Q]B1BFZU0U,+/+BJ9;AG0SW#F@\+M7!E+UA2968O5ULQ(#(@,5T^/G-T')E9@T*,3$V#0HE)45/
#1@T*
`
end